.INVESTIGATION FEATURE.06 August 2024.
A huge randomized controlled test along with cisgender ladies highlights the obstacles of fidelity to a day-to-day oral preexposure prophylaxis regiment and also shows that twice-yearly shot of lenacapavir may maintain successful HIV avoidance amounts over 6 months.